Basilea to launch Zevtera(r)/Mabelio(r) (ceftobiprole medocaril) in Europe through a commercial services provider. Basilea Pharmaceutica Ltd. (SIX: BSLN) reports that ...
CTI BioPharma Corp. (CTI) announced today that it has received approval from the Israeli Ministry of Health (MOH) for PIXUVRI® ...
AIDS can be brought under control by 2030, according to a report by the United Nations Aids agency. It said ...
AbbVie has now laid on the table a bid of £53.20 a share to acquire UK-headquartered Shire, up from last ...
Boehringer Ingelheim has re-evaluated its strategy in hepatitis C (HCV), and as a result the company has decided not to ...
Britons can now get a quick HIV test — in 60 seconds flat, when they visit a supermarket. A British ...
The takeover drama of Britain's AstraZeneca by US drugs giant Pfizer has now reached British prime minister David Cameron's doorstep. In ...
The future of medicine, we're often told, will be personalized. We'll have gene therapies, wearables to monitor our vital signs—maybe ...
UK-based AstraZeneca has reported results from its longest, randomised, head-to-head DURATION-3 trial of exenatide once-weekly, a long-acting glucagon-like peptide-1 (GLP-1) ...
Teva Pharmaceutical has obtained marketing authorisation approval from European Commission for its DuoResp Spiromax for treatment of patients with asthma ...
Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.
